Ep139: Kevin Conroy on Early Detection of Cancer
The Long Run with Luke Timmerman
00:00
The Importance of Cologuard in Clinical Development
Cologuard CEO: "We didn't cut any corners in our original conversations with the FDA, they actually wanted us to run a smaller study" Cologuard is seeking approval for its colonoscopy screening test. The company has raised more than $100 million from investors so far.
Play episode from 39:21
Transcript
